文献速递老年慢病共病管理衰弱、肌少症与跌倒

老年人血浆氨基酸与多重共病的前瞻性关联

Prospective Association Between Plasma Amino Acids and Multimorbidity in Older Adults.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2023-01-01

调整社会人口学、社会经济地位和生活方式后,谷氨酰胺、异亮氨酸和缬氨酸浓度较高与多重共病评分较高显著相关;BMI可能影响异亮氨酸与多重共病的关系。

要点

  • 谷氨酰胺、异亮氨酸和缬氨酸浓度较高与多重共病评分较高前瞻性相关。
  • 支链氨基酸和谷氨酰胺或可作为老年人多重共病的风险标志物。

核心结论

  • 谷氨酰胺、异亮氨酸和缬氨酸与老年人多重共病评分前瞻性正相关,可能作为风险标志物。

研究设计与样本

  • 基线及随访2年时采集血样,并与电子健康记录链接,慢性病归为60种互斥情况。
  • 采用广义估计方程模型分析血浆氨基酸与多重共病的关系,调整社会人口学、社会经济地位和生活方式。

主要发现

  • 基线平均年龄73.6岁(SD=4.2),女性占49.6%。
  • 谷氨酰胺每升高1 mmol/l,多重共病评分增加10.1(95%CI 3.7–16.6)。
  • 异亮氨酸每升高1 mmol/l,多重共病评分增加50.3(95%CI 21.7–78.9)。
  • 缬氨酸每升高1 mmol/l,多重共病评分增加15.5(95%CI 3.1–28.0)。

关键数值与推荐

  • 多重共病采用定量评分,按疾病对躯体功能的回归系数加权,范围0–100。
  • 慢性病归为60种互斥情况。
  • 调整潜在混杂因素后,谷氨酰胺、异亮氨酸和缬氨酸与多重共病评分显著正相关。

临床怎么用

  • 在老年多重共病风险评估中,可关注血浆谷氨酰胺、异亮氨酸和缬氨酸水平。
  • 对异亮氨酸水平较高的老年人,评估多重共病风险时需考虑BMI的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Some amino acids have been associated with aging-related disorders and risk of physical impairment. The aim of this study was to assess the association between plasma concentrations of 9 amino acids, including branched-chain and aromatic amino acids, and multimorbidity. METHODS: This research uses longitudinal data from the Seniors-ENRICA 2 study, a population-based cohort from Spain that comprises noninstitutionalized adults older than 65. Blood samples were extracted at baseline and after a follow-up period of 2 years for a total of 1 488 subjects. Participants' information was linked with electronic health records. Chronic diseases were grouped into a list of 60 mutually exclusive conditions. A quantitative measure of multimorbidity, weighting morbidities by their regression coefficients on physical functioning, was employed and ranged from 0 to 100. Generalized estimating equation models were used to explore the relationship between plasma amino acids and multimorbidity, adjusting for sociodemographics, socioeconomic status, and lifestyle behaviors. RESULTS: The mean age of participants at baseline was 73.6 (SD = 4.2) years, 49.6% were women. Higher concentrations of glutamine (coef. per mmol/l [95% confidence interval] = 10.1 [3.7, 16.6]), isoleucine (50.3 [21.7, 78.9]), and valine (15.5 [3.1, 28.0]) were significantly associated with higher multimorbidity scores, after adjusting for potential confounders. Body mass index could have influenced the relationship between isoleucine and multimorbidity (p = .016). CONCLUSIONS: Amino acids could play a role in regulating aging-related diseases. Glutamine and branched-chain amino acids as isoleucine and valine are prospectively associated and could serve as risk markers for multimorbidity in older adults.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Caballero FF, Lana A, Struijk EA, et al. Prospective Association Between Plasma Amino Acids and Multimorbidity in Older Adults. J Gerontol A Biol Sci Med Sci. 2023. PMID: 35876753. doi:10.1093/gerona/glac144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。